Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.

A novel hyaluronic acid-poly(ethylene glycol)-poly(lactide-co-glycolide) (HA-PEG-PLGA) copolymer was synthesized and characterized by infrared and nuclear magnetic resonance spectroscopy. The nanoparticles of doxorubicin (DOX)-loaded HA-PEG-PLGA were prepared and compared with monomethoxy(polyethylene glycol) (MPEG)-PLGA nanoparticles. Nanoparticles were prepared using drug-to-polymer ratios of 1:1 to 1:3. Drug-to-polymer ratio of 1:1 is considered the optimum formulation on the basis of low particle size and high entrapment efficiency. The optimized nanoparticles were characterized for morphology, particle size measurements, differential scanning calorimetry, x-ray diffractometer measurement, drug content, hemolytic toxicity, subacute toxicity, and in vitro DOX release. The in vitro DOX release study was performed at pH 7.4 using a dialysis membrane. HA-PEG-PLGA nanoparticles were able to sustain the release for up to 15 days. The tissue distribution studies were performed with DOX-loaded HA-PEG-PLGA and MPEG-PLGA nanoparticles after intravenous (IV) injection in Ehrlich ascites tumor-bearing mice. The tissue distribution studies showed a higher concentration of DOX in the tumor as compared with MPEG-PLGA nanoparticles. The in vivo tumor inhibition study was also performed after IV injection of DOX-loaded HA-PEG-PLGA nanoparticles up to 15 days. DOX-loaded HA-PEG-PLGA nanoparticles were able to deliver a higher amount of DOX as compared with MPEG-PLGA nanoparticles. The DOX-loaded HA-PEG-PLGA nanoparticles reduced tumor volume significantly as compared with MPEG-PLGA nanoparticles.

[1]  L. Anghileri.  In vivo synthesis of acid mucopolysaccharides by Ehrlich ascites tumor cells , 1976, Zeitschrift für Krebsforschung und Klinische Onkologie.

[2]  J. Y. Zhang,et al.  Apoptosis-based anticancer drugs , 2002, Nature Reviews Drug Discovery.

[3]  M. Tammi,et al.  Hyaluronan binding by cell surface CD44. , 2000, The Journal of biological chemistry.

[4]  P. Heldin,et al.  Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells. , 1994, Cancer research.

[5]  J. Ryu,et al.  Preparation of Core-shell Type Nanoparticles of Poly($\varepsilon$-caprolactone) /Poly(ethylene glycol)/Poly( $\varepsilon$-caprolactone) Triblock Copolymers , 2001 .

[6]  K. Avgoustakis,et al.  Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers. , 2005, International journal of pharmaceutics.

[7]  L. Lim,et al.  Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Y. Byun,et al.  Heparin-deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[9]  P. Caliceti,et al.  Folate-mediated targeting of polymeric conjugates of gemcitabine. , 2006, International journal of pharmaceutics.

[10]  P. Couvreur,et al.  Surface-engineered nanoparticles for multiple ligand coupling. , 2003, Biomaterials.

[11]  U. Günthert,et al.  Current Topics in Microbiology and Immunology (1993) Volume on Adhesion in Leukocyte Homing and Differentiation (eds D. Dunon, C. R. Mackay, and B. A. Imhof) CD44: a multitude of isoforms with diverse functions , 2007 .

[12]  Y. M. Lee,et al.  Clonazepam release from core-shell type nanoparticles in vitro. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[13]  E. K. Park,et al.  Preparation and characterization of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. , 2004, Biomaterials.

[14]  G. Prestwich,et al.  Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[15]  R. Durand,et al.  Pentamidine‐loaded poly(D,L‐lactide) nanoparticles: Adsorption and drug release , 1998 .

[16]  S. Feng,et al.  Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. , 2004, Biomaterials.

[17]  M. Culty,et al.  The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan , 1992, The Journal of cell biology.

[18]  S. Nie,et al.  Targeted cancer nanotherapy , 2005 .

[19]  D. Coradini,et al.  Hyaluronic acid as drug delivery for sodium butyrate: Improvement of the anti‐proliferative activity on a breast‐cancer cell line , 1999, International journal of cancer.

[20]  D. Chung,et al.  Poly(d,l-lactide-ran-ε-caprolactone)-poly(ethylene glycol)-poly(d,l-lactide-ran-ε-caprolactone) as parenteral drug-delivery systems , 2004 .

[21]  P. Watson,et al.  The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  C. Gilon,et al.  Attachment of drugs to polyethylene glycols , 1983 .

[23]  Weiliam Chen,et al.  Hyaluronan microspheres for sustained gene delivery and site-specific targeting. , 2004, Biomaterials.

[24]  Robert Gurny,et al.  Drug-loaded nanoparticles : preparation methods and drug targeting issues , 1993 .

[25]  I. Stamenkovic,et al.  Inhibition of tumor growth in vivo by hyaluronan oligomers , 1998, International journal of cancer.

[26]  G. Prestwich,et al.  Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. , 1999, Bioconjugate chemistry.

[27]  R. Müller,et al.  'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.

[28]  Y. M. Lee,et al.  Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(epsilon-caprolactone) as novel anticancer drug carriers. , 2001, Biomaterials.

[29]  R. Langer,et al.  Poly(Ethylene Oxide)-Modified Poly(β-Amino Ester) Nanoparticles as a pH-Sensitive System for Tumor-Targeted Delivery of Hydrophobic Drugs: Part 2. In Vivo Distribution and Tumor Localization Studies , 2005, Pharmaceutical Research.

[30]  S. Nedvetzki,et al.  CD44 in Cancer , 2002, Critical reviews in clinical laboratory sciences.

[31]  Hua Ai,et al.  Micellar carriers based on block copolymers of poly(ε-caprolactone) and poly(ethylene glycol) for doxorubicin delivery , 2004 .

[32]  Ilia Fishbein,et al.  Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics. , 2002, Journal of controlled release : official journal of the Controlled Release Society.